Searchable abstracts of presentations at key conferences in endocrinology

ea0090oc8.5 | Oral Communications 8: Calcium and Bone | ECE2023

A vitamin D receptor antagonist as a potent and safe treatment for Idiopathic Infantile Hypercalcemia

Rovito Daniela , Lutzing Regis , Keime Celine , Metzger Daniel , Linglart Agnes , Laverny Gilles

Idiopathic Infantile Hypercalcemia (IIH) is a rare inborn form of severe vitamin D hypersensitivity, with an estimated incidence of 1:33.000 live birth and a high degree of misdiagnosis. Since the identification of CYP24A1 loss-of-function variants inducing IIH in 2011, over 41 pathogenic variants have been described, and represent the major genetic drivers of IIH1. CYP24A1 encodes the main catalytic hydroxylase of the bioactive form of vitamin D (1,25D3). Upon bind...